Literature DB >> 1378872

Effect of granulocyte colony-stimulating factor on sepsis-induced changes in neutrophil accumulation and organ glucose uptake.

C H Lang1, G J Bagby, C Dobrescu, S Nelson, J J Spitzer.   

Abstract

Neutropenia was seen in rats made septic by subcutaneous (sc) injection of Escherichia coli. The sepsis-induced increase in glucose uptake by tissues distant from the site of infection was not associated with increased myeloperoxidase (MPO) activity. Only the skin and muscle at the site of infection demonstrated an increase in both glucose uptake and MPO activity. Granulocyte colony-stimulating factor (G-CSF) attenuated the sepsis-induced decrease in circulating neutrophils. Both glucose uptake and MPO activity of skin and muscle adjacent to the infection site showed a smaller increase in G-CSF treated rats. In contrast, septic rats injected with G-CSF exhibited a greater number of leukocytes and a larger reduction in the number of bacteria in the sc lavage fluid. These results demonstrate that G-CSF is a potent immunomodulator that stimulates neutrophil function and also increases their recruitment to the site of infection, resulting in improved bacterial killing and host defense.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378872     DOI: 10.1093/infdis/166.2.336

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

1.  Skeletal and cardiac myopathy in HIV-1 transgenic rats.

Authors:  Anne M Pruznak; Ly Hong-Brown; Rachel Lantry; Pengxiang She; Robert A Frost; Thomas C Vary; Charles H Lang
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-08-19       Impact factor: 4.310

2.  Activation of neutrophil function by recombinant human granulocyte colony-stimulating factor improves the survival of rats with peritonitis.

Authors:  H Ishikura; Y Uedono; K Yamagami; T Arai; N Takeyama; T Tanaka
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  Effects of granulocyte colony-stimulating factor on bacterial translocation due to burn wound sepsis.

Authors:  O Yalçin; G Soybir; F Köksoy; H Köse; R Oztürk; B Cokneşeli
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

4.  Perioperative recombinant human granulocyte colony-stimulating factor (Filgrastim) treatment prevents immunoinflammatory dysfunction associated with major surgery.

Authors:  Christian Schneider; Sonja von Aulock; Siegfried Zedler; Christian Schinkel; Thomas Hartung; Eugen Faist
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

5.  Effects of granulocyte colony-stimulating factor (G-CSF) treatment on granulocyte function and receptor expression in patients with ventilator-dependent pneumonia.

Authors:  W N Hustinx; C P Van Kessel; E Heezius; S Burgers; J W Lammers; I M Hoepelman
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.